Nurix Therapeutics, Inc. (NRIX)
19.54
-1.93
(-8.99%)
USD |
NASDAQ |
Dec 09, 16:00
19.54
0.00 (0.00%)
After-Hours: 20:00
Nurix Therapeutics Total Assets (Quarterly): 522.47M for Aug. 31, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Gilead Sciences, Inc. | 58.53B |
| Pfizer Inc. | 208.73B |
| EyePoint Pharmaceuticals, Inc. | 251.70M |
| GT Biopharma, Inc. | 4.321M |
| KalVista Pharmaceuticals, Inc. | 339.93M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 150.22M |
| Shareholders Equity (Quarterly) | 372.25M |
| Debt to Equity Ratio | 0.1517 |
| Current Ratio | 5.350 |
| Net Debt Paydown Yield | -0.77% |